Seeking Alpha

Alexza Pharmaceuticals (ALXA +41%) is soaring today on no specific news. One possible lead could...

Alexza Pharmaceuticals (ALXA +41%) is soaring today on no specific news. One possible lead could come from the company's earnings call transcript, released late Friday. It provided further color on recent inspections by both the EMA and FDA on its Mountain View facility, and an update on the anticipated approval of its schizophrenia and bipolar disorder drug Adsuasive, which is expected to get clearance in both Europe and the U.S. later this year. (Transcript)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs